Amundi MSCI UK IMI SRI PAB UCITS ETF DR - GBP (GBP) | FT1KRegistrer dig for at låse op for ratings |
Fondens performance | 30-04-2024 |
Vækst af 1.000 (DKK) | Avanceret graf |
Fond | -17,4 | 19,9 | -98,6 | 12,5 | 5,0 | |
+/-Kat | -3,1 | -5,8 | -91,3 | 1,4 | -2,1 | |
+/-Indeks | - | - | - | 2,0 | -2,8 | |
Kategori: Aktier - England Large Cap | ||||||
Kategoribenchmark: Morningstar UK All Cap TME ... |
Oversigt | ||
Closing Price 02-05-2024 | GBX 1117,60 | |
Kursændring 1 dag | 0,67% | |
Morningstar Kategori™ | Aktier - England Large Cap | |
Omsætning | 0 | |
Børs | LONDON STOCK EXCHANGE, THE | |
ISIN | LU1437025296 | |
Markedsværdi i alt (mio.) 30-04-2024 | EUR 147,91 | |
Seneste TNA(mio.) 30-04-2024 | GBP 44,42 | |
Løbende omkostning 10-02-2023 | 0,18% | |
Investeringsstrategi | Passiv |
Investeringsmålsætning: Amundi MSCI UK IMI SRI PAB UCITS ETF DR - GBP (GBP) | FT1K |
To track the performance of MSCI UK IMI SRI Filtered PAB Index (the "Index"), and to minimize the tracking error between the net asset value of the sub-fund and the performance of the Index. |
Returns | |||||||||||||
|
Management | ||
Manager navn Startdato | ||
Navarre Pierre 23-03-2022 | ||
Isabelle Lafargue 23-03-2022 | ||
Klik her for at se flere | ||
Startdato 13-12-2016 |
Annonce |
Kategoribenchmark | |
Fondens indeks | Morningstar indeks |
MSCI UK IMI filtered PAB NR GBP | Morningstar UK All Cap TME NR GBP |
Target Market | ||||||||||||||||||||
|
Formuefordeling Amundi MSCI UK IMI SRI PAB UCITS ETF DR - GBP (GBP) | FT1K | 29-04-2024 |
|
|
Top 5 placeringer | Sektor | % |
AstraZeneca PLC | Healthcare | 5,51 |
RELX PLC | Industri | 4,60 |
London Stock Exchange Group PLC | Finans | 4,52 |
Lloyds Banking Group PLC | Finans | 4,16 |
Reckitt Benckiser Group PLC | Forbrugsvarer | 3,68 |
Øget Mindsket Ny siden sidste portefølje | ||
Amundi MSCI UK IMI SRI PAB UCITS ETF DR - GBP (GBP) | FT1K |